A novel multi-center study, serving as the largest pilot study for BRCA clinical testing in Nigeria to evaluate treatment & patient outcomes.

Study Outcomes

Feasibility of saliva based BRCA1/2 remote genetic testing

Evaluate the feasibility, acceptability, and cost-effectiveness

Prevalence of BRCA1/2 mutation

Determine the proportion of BC patients with BRCA1/ BRCA2 mutations

Treatment related events

Review of type of surgery, treatment, and oncologic outcomes

Patient reported outcome measures

The Multidimensional Impact of Cancer Risk Assessment (MICRA) tool will measure the impact of result disclosure after genetic testing

Patient experience

Evaluate patient perceptions and experience post-surgery

100